Real-time enrollment status for this chronic urticaria clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 6:58 AM UTC
| NCT Number | NCT06931405 |
| Recruiting Status | Recruiting |
| Condition | Chronic Urticaria |
| Phase | PHASE2 |
| Target Enrollment | 105 participants |
| Active Locations | 27 sites in the US |
| Sponsor | Blueprint Medicines Corporation |
| Last Updated on CT.gov | February 17, 2026 (Feb 17, 2026) |
As of July 18, 2026: Clinical trial NCT06931405 is currently recruiting participants. This phase2 study for chronic urticaria is actively seeking new participants at 27 locations across the United States. The study is sponsored by Blueprint Medicines Corporation. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06931405 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 27 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06931405 was last updated Feb 17, 2026 (February 17, 2026). HelloStudys verifies this status automatically.